Newsroom

Group photo Kick off
News
In March 2026, the Europe-wide doctoral program “UNLIMITED – Understanding Lipid Immunometabolism to Treat Disease” was launched under the leadership of the University Medical Center Mainz. In cooperation with the Technische Universität Braunschweig, a doctoral position will also be established in a research group at the Helmholtz Centre for Infection Research (HZI). The project is funded by the European Commission under the prestigious Marie Skłodowska-Curie Actions (MSCA) with a total of 4.5 million euros and is one of 149 doctoral networks currently funded across the EU.
16.04.2026
phage attack
News
The CRISPR-Cas gene-editing system has long been the focus of research as a promising tool in genome editing. However, the emphasis has been on its underlying mechanisms and nucleases. In contrast, little research has examined how CRISPR-Cas systems have evolved and been optimized. In collaboration with the universities of Leipzig, Freiburg, and Michigan (USA), a research team at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg found an optimization mechanism in CRISPR-Cas13, providing insights into the evolution of these systems. The results were recently published in EMBO Journal.
14.04.2026
Section of a mouse dorsal root ganglion with two subtypes of pain receptors marked in cyan and magenta.
News
Helmholtz researchers have created the first detailed protein map of specific sensory neurons that trigger pain. The team from the Max Delbrück Center and the Helmholtz Centre for Infection Research (HZI) determined the complete set of proteins in nerve cells and generated a high-resolution map of the cells. Their study, published in “Nature Communications,” will help researchers better understand the molecular mechanisms of chronic inflammatory pain and identify new drug targets.
14.04.2026
Dot-like colonies of the bacterium Klebsiella pneumoniae (blue) on a round plate
News
Antimicrobial resistance is one of the greatest challenges to global health. Using an innovative high-throughput method, researchers from the Department “Epidemiology and Ecology of Antimicrobial Resistance” led by Prof. Katharina Schaufler at the Helmholtz Institute for One Health (HIOH) have now uncovered a previously hidden link between antibiotic resistance and virulence in Klebsiella pneumoniae. Virulence describes the extent to which a pathogen can cause disease. The findings were published in the international journal Clinical Microbiology and Infection. HIOH is a site of the Helmholtz Centre for Infection Research.
13.04.2026
Group photo of about 100 people on the steps in front of a building entrance
News
Even after the COVID-19 pandemic, infectious diseases remain among the greatest challenges to global health. At the same time, advances in biomedical research, data-driven methods, and clinical innovation are opening up new opportunities to tailor prevention, diagnosis, and treatment to individual patients. How these approaches can be translated into medical care was the focus of the 2nd International Conference on Individualized Infection Medicine, which took place from March 19 to 21, 2026, at Herrenhausen Palace in Hannover.
09.04.2026
A man and a woman, who holds a certificate
News
Dr. Lina Herhaus has been awarded the Otto Meyerhof Award of the German Society for Biochemistry and Molecular Biology (GBM e.V.) at the 77th Mosbacher Kolloquium of the GBM. The prize, endowed with €5,000 and funded by Boehringer Ingelheim, was presented for the seventh time and recognizes outstanding early-career scientists conducting research in Germany in fields relevant to the GBM within biochemistry and molecular biology. The award commemorates the world-renowned physiologist and biochemist Otto Meyerhof, who worked in Kiel, Berlin, and Heidelberg before being forced to flee Germany in 1938 as a Jewish scientist.
31.03.2026

HZI in the media

... “

 

Das Helmholtz-Zentrum für Infektionsforschung: Wissenschaftler:innen am Helmholtz-Zentrum für Infektionsforschung (HZI) untersuchen ...

22.10.2026
|
DeutschesGesundheitsPortal

... Lange, Leiterin der Abteilung Epidemiologie am Helmholtz-Zentrum für Infektionsforschung in Braunschweig und Mitglied der Ständigen ...

22.10.2026
|
DIE WELT

... befallen. Am HZI in Braunschweig wird daran geforscht.

 

Am Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig ...

22.10.2026
|
NDR Norddeutscher Rundfunk

are extremely complex.

 

Researchers at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) have now shown that artificial

21.10.2026
|
Phys.org

Würzburg (JMU) und dem Helmholtz-Institut für RNA-basierte Infektionsforschung (HIRI), einem Standort des HZI in ...

20.10.2026
|
Regional Heute

community. HIPS is a site of the Helmholtz Centre for Infection Research (HZI) that operates in collaboration with Saarland University.

20.10.2026
|
WDC Tv News

... Verabreichung eintritt. Expertin Berit Lange vom Helmholtz-Zentrum für Infektionsforschung betonte, dass jetzt der richtige Moment ...

16.10.2026
|
upday

... Berit Lange im Gespräch mit FOCUS online. Sie ist Leiterin der Abteilung Epidemiologie am Helmholtz-Zentrum ...

16.10.2026
|
Focus Online

protection against BV. Researchers from the Helmholtz Centre for Infection Research have reported evidence that antibodies produced after

16.10.2026
|
Medscape

... ist Leiterin der Abteilung Epidemiologie am Helmholtz-Zentrum für Infektionsforschung in Braunschweig und Mitglied der Ständigen ...

16.10.2026
|
Berliner Morgenpost

... beeindruckendes Ergebnis“, sagt Jakob Wirbel vom Helmholtz-Zentrum für Infektionsforschung (HZI). „Trotzdem schlafe ich momentan noch ...

15.10.2026
|
Der Tagesspiegel

also included Japanese microbiologists and collaborators from IST Austria and HZI Braunschweig (Germany), demonstrated that actin inhibitors

14.10.2026
|
Health Medicine Network

Register now for the HZI newsletter